Thymomas are non-frequent neoplasias which are interesting because of their special association with the immune system pathology; although the pathogenic relationship has yet to be confirmed. A literature review is carried out on clinical aspects, prognosis and treatment, basically chemotherapy in advanced cases. Although they are classically categorized as benign, they are nevertheless considerably aggressive and maintain a low response to most active oncology treatment.